Prostamax (50mg)

What is Prostamax (50mg)?

Prostamax (50mg) is a synthetic tetrapeptide composed of four amino acids with the sequence Lys-Glu-Asp-Pro. It belongs to a group of short regulatory peptides, sometimes referred to as Khavinson peptides, which are studied in laboratory settings for their potential involvement in gene regulation and cellular signaling pathways.

• Chemical Formula: C₂₀H₃₃N₅O₉
• Molecular Weight: 487.5 g/mol

The molecule consists of a short peptide chain designed for research applications involving peptide bioregulators. Research-grade preparations are typically manufactured to high-purity levels and verified through analytical testing. In experimental models, Prostamax has been studied in investigations involving cellular regulatory processes and tissue-specific peptide signaling.

What are the key features of Prostamax (50mg)?

• Synthetic tetrapeptide composed of four amino acids (Lys-Glu-Asp-Pro)
• Supplied as 50 mg lyophilized peptide in sealed vial format
• High analytical purity verified through laboratory testing
• Studied in peptide bioregulator and cellular signaling research models
• For laboratory research use only

How is Prostamax (50mg) synthesized?

Prostamax (50mg) is typically produced using solid-phase peptide synthesis (SPPS), a standard technique for constructing peptides with defined amino acid sequences. During this process, the four-amino-acid chain is assembled step-by-step on a solid support, ensuring accurate formation of the Lys-Glu-Asp-Pro sequence. Following synthesis, purification is performed by high-performance liquid chromatography (HPLC) to ensure high purity. Analytical verification of molecular weight and structural identity is commonly conducted using mass spectrometry (MS). The purified peptide is then lyophilized to improve stability during storage and transportation for research use.

What is Prostamax (50mg) being studied for? What are its possible benefits?

In experimental research, Prostamax (50mg) has been investigated in studies examining short regulatory peptides and their potential effects on cellular function. Tetrapeptides in this category are being researched for their potential involvement in tissue-specific signaling and gene expression regulation. Research areas associated with Prostamax include:

• Cellular signaling and regulatory peptide research
• Gene expression modulation in laboratory models
• Cell proliferation and differentiation studies
• Age-related cellular process investigations
• Experimental tissue biology research

Some laboratory findings suggest that peptides in this group may interact with chromatin or nuclear proteins involved in transcriptional regulation. These potential effects remain under investigation and are limited to controlled experimental studies.

How does Prostamax (50mg) work in research studies?

In laboratory models, Prostamax (50mg) is studied as a peptide bioregulator, meaning it may influence cellular regulatory processes through interactions with intracellular molecular systems. Short peptides such as Lys-Glu-Asp-Pro are investigated for their ability to interact with proteins involved in DNA structure and transcriptional regulation. Experimental studies suggest that regulatory peptides may influence gene expression by interacting with chromatin-associated proteins or signaling molecules inside cells. Through these mechanisms, Prostamax is being researched for its potential role in cellular communication and tissue-specific regulatory pathways. These mechanisms remain experimental and are still being explored in research environments.

What dosing information exists for Prostamax (50mg)?

Most available dosing information for Prostamax (50mg) comes from preclinical research involving cell culture experiments and animal studies. In vitro research typically evaluates peptide activity at nanomolar to micromolar concentrations to observe cellular responses. Some experimental animal studies involving regulatory peptides have explored dosing ranges in the microgram per kilogram (µg/kg) range, depending on the study objective and biological model used. However, research protocols vary significantly. There are currently no established human dosing guidelines, as Prostamax is intended exclusively for laboratory research applications.

How should Prostamax (50mg) be stored and handled?

• Store under controlled laboratory conditions to maintain peptide stability.
• Recommended standard storage is 2–8 °C. For long-term preservation, store at ≤–20 °C.
• Protect the lyophilized peptide from light, heat, and moisture.
• Room-temperature exposure during transport is generally acceptable for short durations.
• After reconstitution with sterile laboratory-grade solvent, solutions should typically be stored at 2–8 °C for short-term use.
• Repeated freeze-thaw cycles should be avoided, as they may compromise peptide integrity.
• Follow standard laboratory safety protocols during handling and disposal.

Where can I read more research about Prostamax (50mg)?

1. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053. Published 2021 Nov 22. doi:10.3390/molecules26227053
2. Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. Int J Mol Sci. 2022;23(14):7733. Published 2022 Jul 13. doi:10.3390/ijms23147733
3. Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules. 2023;13(3):552. Published 2023 Mar 17. doi:10.3390/biom13030552
4. National Center for Biotechnology Information. PubChem Compound Summary for CID 9848296, Prostamax. https://pubchem.ncbi.nlm.nih.gov/compound/Prostamax

 

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.